Aigen Investment Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-23,719
| Closed | -$257K | – | 956 |
|
2023
Q1 | $257K | Buy |
+23,719
| New | +$257K | 0.04% | 465 |
|
2020
Q4 | – | Sell |
-4,663
| Closed | -$69K | – | 1039 |
|
2020
Q3 | $69K | Sell |
4,663
-8,766
| -65% | -$130K | 0.01% | 754 |
|
2020
Q2 | $282K | Buy |
13,429
+3,477
| +35% | +$73K | 0.04% | 630 |
|
2020
Q1 | $230K | Buy |
9,952
+9,933
| +52,279% | +$230K | 0.03% | 664 |
|
2019
Q4 | $0 | Buy |
+19
| New | – | ﹤0.01% | 1147 |
|